23 results on '"Parr, S."'
Search Results
2. PRO61 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS CAREGIVER BURDEN STUDY
3. Trade and investment agreements: Implications for health protection
4. Patient Goup Experiences of Engagement in Health Technology Appraisals for Rare Disease Treatments - A Pilot Study in the UK
5. Anabolic payout of terminal implant alters adipogenic gene expression of the longissimus muscle in beef steers1
6. Contrasting The Characteristics Of Hta Submissions For Rare Versus Ultra-Rare Diseases
7. Analysis of the effect of different absorber materials and loading on the shielding effectiveness of a metallic enclosure
8. PSY127 - Patient Goup Experiences of Engagement in Health Technology Appraisals for Rare Disease Treatments - A Pilot Study in the UK
9. PHP42 - Contrasting The Characteristics Of Hta Submissions For Rare Versus Ultra-Rare Diseases
10. Concepts of Human Development and Poverty: A Multidimensional Perspective
11. Gender Inequality in Human Development: Theories and Measurement
12. Human Development Index: Methodology and Measurement
13. Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema.
14. Point-process modeling of secondary crashes.
15. Bias in Foundation Models: Primum Non Nocere or Caveat Emptor?
16. A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosis.
17. Gender and COVID-19: Workers in global value chains.
18. Pandemic treaty needs to start with rethinking the paradigm of global health security.
19. Editorial: the political determinants of health inequities and universal health coverage.
20. Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group.
21. Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR.
22. Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report.
23. Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.